You have accessJournal of UrologyProstate Cancer: Localized IX1 Apr 20121824 EJACULATION PRESERVATION FOLLOWING ROBOTIC PROSTATECTOMY: DESCRIPTION OF A NOVEL TECHNIQUE AND PRELIMINARY RESULTS Danielle Brooks, Bekheit Salamoon, Abhishek Srivastava, Siobhan Gruschow, Alexandra Peyser, and Ashutosh Tewari Danielle BrooksDanielle Brooks New York, NY More articles by this author , Bekheit SalamoonBekheit Salamoon New York, NY More articles by this author , Abhishek SrivastavaAbhishek Srivastava New York, NY More articles by this author , Siobhan GruschowSiobhan Gruschow New York, NY More articles by this author , Alexandra PeyserAlexandra Peyser New York, NY More articles by this author , and Ashutosh TewariAshutosh Tewari New York, NY More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2012.02.1890AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES While several technical modifications have been described to overcome the side effects following robotic assisted radical prostatectomy (RALP), there is one side effect that has so far never been addressed; that is, is the inability to ejaculate following prostate cancer surgery. In this manuscript, we present a feasibility study and describe our technique of seminal vesicle reattachment to the bladder neck in three patients such that ejaculation is preserved after surgery. METHODS This is an Institutional Review Board (IRB) approved study involving three patients with clinically localized prostate cancer. After informed consent, all of these patients underwent preservation of the entire seminal vesicles and distal vasa deferentia with an intact neurovascular supply and had a common channel seminal vesicle re-anastomosis to the bladder neck. The patients who reported to have achieved ejaculation were tested for presence of fructose in the ejaculate to differentiate it from climaturia. These patients were tested for fructose post operatively to confirm the success of ejaculation-sparing surgery. Continence recovery was defined as the use of zero pads or one security liner per 24 hours. Sexual function recovery was defined as a score of >21 on SHIM questionnaire. RESULTS All three men were continent, potent, having orgasm at 3, 6 and 12 months. All three men reported having achieved ejaculation postoperatively. Two of the three patients had fructose positive ejaculate; the third patient has so far not sent ejaculate for biochemical evaluation. CONCLUSIONS RALP with ejaculation preservation in men with low-grade prostate cancer is feasible and reproducible. We were able to preserve postoperative ejaculation and orgasm without compromising oncological outcomes at one year follow up. This novel procedure could improve the quality of life of patients undergoing surgery for prostate cancer. © 2012 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 187Issue 4SApril 2012Page: e737 Peer Review Report Advertisement Copyright & Permissions© 2012 by American Urological Association Education and Research, Inc.MetricsAuthor Information Danielle Brooks New York, NY More articles by this author Bekheit Salamoon New York, NY More articles by this author Abhishek Srivastava New York, NY More articles by this author Siobhan Gruschow New York, NY More articles by this author Alexandra Peyser New York, NY More articles by this author Ashutosh Tewari New York, NY More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...